JAK2 and myeloproliferative neoplasm: A similar type of observation has been made in human MPNs where endothelial cells in certain vessels were found to carry the JAK2 V617F mutation, especially in patients with Budd-Chiari syndrome and portal vein thrombosis and thus to be derived from the MPN stem cell [72].